| CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI)|CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI) 基本信息 更多信息 |
中文名称: | CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI) | 中文同义词: | 化合物 T29100;化合物 VCH-286 | 英文名称: | CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI) | 英文同义词: | CCR5 antagonist (freebase);CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI);YZGXEGUSPLSQOJ-MJOCGKAJSA-N;VCH-286;CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3-(1-Methylethyl)-2-oxo-1-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI);Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[3'-(1-methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)methyl]spiro[(3-exo)-8-azabicyclo[3.2.1]octane-3,4'-imidazolidin]-8-yl]-1-phenylpropyl]- | CAS号: | 891824-47-8 | 分子式: | C34H50F2N4O3 | 分子量: | 600.8 | EINECS号: | | |
|
按国家浏览CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI)国外供应商 |
中国供应商 |
CyclohexanecarboxaMide, 4,4-difluoro-N-[(1S)-3-[(1α,3α,5α)-3'-(1-Methylethyl)-2'-oxo-1'-[(tetrahydro-2H-pyran-4-yl)Methyl]spiro[8-azabicyclo[3.2.1]octane-3,4'-iMidazolidin]-8-yl]-1-phenylpropyl]- (9CI) 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|